Start the conversation
Biotech stocks find themselves in a very interesting, and potentially very profitable, situation right now.
It's widely believed by public health officials that we can't return to "normal" until scientists discover a coronavirus vaccine that can be widely distributed.
That's the primary reason why the Trump administration launched "Operation Warp Speed."
The U.S. government is investing billions of dollars in biotech companies to develop a COVID-19 vaccine as quickly as possible – so the world can return to normal.
But not all biotech stocks are worth buying right now.